Decoding the regulatory landscape of melanoma reveals TEADS as regulators of the invasive cell state
Open accessThe DOI matches its Crossref record; 71 of the 72 references it cites were found in a registry or an index.
Abstract
Transcriptional reprogramming of proliferative melanoma cells into a phenotypically distinct invasive cell subpopulation is a critical event at the origin of metastatic spreading. Here we generate transcriptome, open chromatin and histone modification maps of melanoma cultures; and integrate this data with existing transcriptome and DNA methylation profiles from tumour biopsies to gain insight into the mechanisms underlying this key reprogramming event. This shows thousands of genomic regulatory regions underlying the proliferative and invasive states, identifying SOX10/MITF and AP-1/TEAD as regulators, respectively. Knockdown of TEADs shows a previously unrecognized role in the invasive gene network and establishes a causative link between these transcription factors, cell invasion and sensitivity to MAPK inhibitors. Using regulatory landscapes and in silico analysis, we show that transcriptional reprogramming underlies the distinct cellular states present in melanoma. Furthermore, it reveals an essential role for the TEADs, linking it to clinically relevant mechanisms such as invasion and resistance.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures








Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“among the SALL4-HDAC2 targets upregulated upon SALL4 knockdown, we found integrins (ITGB1, ITGA6, ITGA4), N-cadherin (CDH2), TGFBR2, VEGFR-1, PDGFC, LOXL2, MAPK8, and many others which are associated with invasive melanoma phenotypes40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [41]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“SALL4-regulated genes showed a significant enrichment and positive correlation with published invasiveness signatures40–42, while they significantly anti-correlated with their corresponding proliferation signatures40–42”
From Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4 (2021) · cites this paper as [41]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Subramanian, A., Tamayo, P., Mootha, V. K., Mukherjee, S., Ebert, B. L., Gillette, M. A., Paulovich, A., Pomeroy, S. L., Golub, T. R., Lander, E. S., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0506580102 · Cited by 53,625
PD-1 and PD-L1 Immune Checkpoint Blockade to Treat Breast Cancer
Hartkopf, A. D., Taran, F.-A., Wallwiener, M., Walter, C. B., Krämer, B., Grischke, E.-M., & Brucker, S. Y. (2016) · Breast Care · doi:10.1159/000453569 · Cited by 30,845
HTSeq—a Python framework to work with high-throughput sequencing data
Anders, S., Pyl, P. T., & Huber, W. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btu638 · Cited by 21,464
Model-based Analysis of ChIP-Seq (MACS)
Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein, B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., et al. (2008) · Genome Biology · doi:10.1186/gb-2008-9-9-r137 · Cited by 18,386
An integrated encyclopedia of DNA elements in the human genome
The ENCODE Project Consortium (2012) · Nature · doi:10.1038/nature11247 · Cited by 18,072
Gene Expression Omnibus: NCBI gene expression and hybridization array data repository
Edgar, R. (2002) · Nucleic Acids Research · doi:10.1093/nar/30.1.207 · Cited by 13,288
Kim, D., Pertea, G., Trapnell, C., Pimentel, H., Kelley, R., & Salzberg, S. L. (2013) · Genome Biology · doi:10.1186/gb-2013-14-4-r36 · Cited by 12,668
The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity
Barretina, J., Caponigro, G., Stransky, N., Venkatesan, K., Margolin, A. A., Kim, S., Wilson, C. J., Lehár, J., Kryukov, G. V., Sonkin, D., et al. (2012) · Nature · doi:10.1038/nature11003 · Cited by 7,950
Cited by
Items 501–529 of 529
Rôle de c-Jun dans la réponse aux inhibiteurs de la voie des MAPK dans les mélanomes
Pohorecka, M. (2018) · theses.fr (ABES) · doi:10.70675/4cf7db7bz9142z4de8zbcbbzd5860991d571
Lecacheur, M. (2021) · theses.fr (ABES) · doi:10.70675/9c0b4d17zd8d8z498ezb534z3096acf22d56
Importance de l'axe AhR/Src dans la reprogrammation des mélanomes métastasiques
Paris, A. (2021) · theses.fr (ABES) · doi:10.70675/aa73ebffz8914z40bazb170z7d5c3e02bc0f
Rôle de MICAL-2, une cible transcriptionnelle de la β-caténine dans le lignage mélanocytaire
Zidi, A. (2024) · theses.fr (ABES) · doi:10.70675/dcaa2485zba8cz47a7zb6d8zf96da7c0d51e
Single-cell lineage tracing maps clonal and transcriptional dynamics in melanoma metastasisPreprint
Li, H., Chen, Y., Kaster, J., Dunne, M., Qi, C., Li, L., Xiao, M., Thomas, M., Promi, N., Fingerman, D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.04.09.717571
Schofield, N., White, R., Baker, R., & Byrne, H. M. (2026) · Bulletin of Mathematical Biology · doi:10.48550/arxiv.2604.24673
Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8Preprint
Kong, H., Choi, J., Zhang, T., Gräwe, C., Xu, M., Thakur, R., Sowards, H., Hennessey, R. C., Vu, A. H., Shi, J., et al. (2026) · eLife · doi:10.7554/elife.110071
Functional characterization of a multi-cancer risk locus on chromosome band 2q33.1 near CASP8Preprint
Kong, H., Choi, J., Zhang, T., Gräwe, C., Xu, M., Thakur, R., Sowards, H., Hennessey, R. C., Vu, A. H., Shi, J., et al. (2026) · eLife · doi:10.7554/elife.110071.1
Bharadwaj, P. K. (2026) · Research Square · doi:10.21203/rs.3.rs-9709612/v1
Brown, L. G., Coleman, I. M., Chu, T. L., Sayar, E., Patel, R. A., Hanratty, B. P., Adil, M., Li, D., Li, Y., Nguyen, H. M., et al. (2026) · Neoplasia · doi:10.1016/j.neo.2026.101321
An Itch Receptor Drives MelanomaPreprint
Gour, N., Atakkatan, A., Akbarzadeh, M., Yong, H. M., Magesh, A., Wu, Z., Joo, H., Chhabra, Y., Peng, J., Weeraratna, A. T., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.06.01.729383
Kisielewska, M., Suwała, S., Drąg‐Zalesińska, M., & Rembiałkowska, N. (2026) · Cell Cycle · doi:10.1080/15384101.2026.2684937
Metabolic buffering restricts phenotype switching in melanoma
Ramírez-Sánchez, A., Jociles-Ortega, M., García-Martínez, J. M., Torrens-Martínez, I., Martínez‐Useros, J., Louphrasitthiphol, P., Sweeney, M. I., Morente-Carrasco, A., Ruiz-Reyes, S., Redondo-Díaz, N., et al. (2026) · The EMBO Journal · doi:10.1038/s44318-026-00857-2
Ahmad, Z. E., Ludwig, K., Matthies, A. O., Bosserhoff, A., & Kappelmann‐Fenzl, M. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27146459
Unique Features of Melanoma Risk and Diagnosis in Red-Haired Populations
Ebrahimi, K., Ostrowski, S. M., & Fisher, D. E. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27177765
An Itch Receptor Drives MelanomaPreprint
Gour, N., Atakkatan, A., Akbarzadeh, M., Yong, H. M., Magesh, A., Wu, Z., Joo, H., Chhabra, Y., Peng, J., Weeraratna, A. T., et al. (2026) · eLife · doi:10.7554/elife.112036.1
An Itch Receptor Drives MelanomaPreprint
Gour, N., Atakkatan, A., Akbarzadeh, M., Yong, H. M., Magesh, A., Wu, Z., Joo, H., Chhabra, Y., Peng, J., Weeraratna, A. T., et al. (2026) · eLife · doi:10.7554/elife.112036
Towards epigenetically informed and biobank-driven precision immunotherapy in melanoma
Ciuffreda, L., Falcone, I., Sorino, C., Valenti, A., Accetta, C., Nicola, F. D., Roglia, V., Fanciulli, M., Blandino, G., Pescarmona, E. O., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1932718
An m5C-associated NSUN5–YBX1–CENPF programme marks melanoma cell states and immune features
Liu, A., Yuan, K., Yi, S., Mao, H., Xie, X., Yin, S., Fan, H., Zhang, A., Liu, X., Hu, Y., et al. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1952519
When do drug holidays delay resistance? A calibrated model of BRAF V600E melanoma
Yang, E. Y. (2026) · Journal of High School Science · doi:10.64336/001c.172768
An Itch Receptor Drives MelanomaPreprint
Gour, N., Atakkatan, A., Akbarzadeh, M., Yong, H. M., Magesh, A., Wu, Z., Joo, H., Chhabra, Y., Peng, J., Weeraratna, A. T., et al. (2026) · eLife · doi:10.7554/elife.112036.2
A cellular hierarchy in melanoma uncouples growth and metastatic phenotypes
梁瀚(Lianghan) (2023) · China National GeneBank DataBase · doi:10.26036/cnp0003961
Metadata
- Authors
- Verfaillie, A., Imrichova, H., Atak, Z. K., Dewaele, M., Rambow, F., Hulselmans, G., Christiaens, V., Svetlichnyy, D., Luciani, F., Van den Mooter, L., Claerhout, S., Fiers, M., Journe, F., Ghanem, G.-E., Herrmann, C., Halder, G., Marine, J.-C., & Aerts, S.
- Affiliations
- KU Leuven (BE)
- VIB-KU Leuven Center for Cancer Biology (BE)
- Université Libre de Bruxelles (BE)
- German Cancer Research Center (DE)
- Corresponding author
- Aerts, Stein
- ORCID
- Venue
- Nature Communications
- Published
- 2015-04-09
- Volume
- 6
- Issue
- 1
- Pages
- 6683-6683
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4403341
- OpenAlex
- W2018433132
- Cited by
- 489
- References
- 72
- Citations by year
- 2026: 27 · 2025: 32 · 2024: 59 · 2023: 56 · 2022: 59 · 2021: 50 · 2020: 56 · 2019: 41 · 2018: 33 · 2017: 39 · 2016: 24 · 2015: 11
- FWCI
- 15.48
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- RePEc: Research Papers in Economics (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion, other-oa)
- Funders
- Fonds Wetenschappelijk Onderzoek
- KU Leuven
- Kom op tegen Kanker
- Fondation contre le Cancer
- Stand Up To Cancer
- Bijzonder Onderzoeksfonds UGent
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Melanoma and MAPK Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Chromatin Remodeling and Cancer
- Keywords
- melanoma, cell invasion, transcriptional reprogramming, TEAD transcription factors, SOX10, MITF, AP-1, MAPK inhibitors, MAPK inhibitor resistance, chromatin accessibility, histone modifications, DNA methylation, metastasis
- MeSH terms
- TEA Domain Transcription Factors, Antineoplastic Agents, Cell Transformation, Neoplastic, Chromatin, DNA-Binding Proteins, Histones, Humans, Melanoma, Neoplasm Invasiveness, Nuclear Proteins, Transcription Factors, Transcription, Genetic, Signal Transduction, Gene Expression Regulation, Neoplastic, Transcription Factor AP-1, DNA Methylation, Protein Isoforms, RNA, Small Interfering, Cell Line, Tumor, Protein Kinase Inhibitors, Microphthalmia-Associated Transcription Factor, Gene Regulatory Networks, SOXE Transcription Factors, Transcriptome, Cellular Reprogramming
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.